A Phase II Study of the Safety and Efficacy of a Novel Oral fXa Inhibitor (LY517717) for the Prevention of Venous Thromboembolism Following TKR or THR.

Autor: Agnelli, Giancarlo *, Haas, Sylvia K. *, Krueger, Kathryn A. *, Bedding, Alun W. *, Brandt, John T.
Zdroj: In Blood 16 November 2005 106(11):278-278
Databáze: ScienceDirect